DNA binding by the CCAAT-displacement protein, the mammalian homologue of the Drosophila melanogaster Cut protein, was previously found to increase sharply in S phase, suggesting a role for CDP/Cut in cell cycle progression. Genetic studies in Drosophila indicated that cut plays an important role in celltype specification in several tissues. In the present study, we have investigated CDP/Cut expression and activity in a panel of multipotent hematopoietic cell lines that can be induced to differentiate in vitro into distinct cell types. While CDP/Cut DNA binding activity declined in the pathways leading to macrophages, granulocytes and erythrocytes, it remained elevated in megakaryocytes. CDP/Cut was also highly expressed in primary megakaryocytes isolated from mouse, and some DNA binding activity could be detected. Altogether, these results raise the possibility that CDP/Cut may be a determinant of cell type identity downstream of the myelo-erythroid precursor cell. Another possibility, which does not exclude a role in lineage identity, is that CDP/Cut activity in megakaryocytes is linked to endomitosis. Indeed, elevated CDP/Cut activity in differentiating megakaryocytes and during the S phase of the cell cycle suggests that it may be required for DNA replication. Leukemia (2000) 14, 863-873.
Introduction
The cDNAs for homologues of the Drosophila melanogaster Cut homeodomain protein have recently been isolated from several mammalian species including human, dog, mouse and rat and were respectively termed CDP (CCAAT displacement protein), Clox (Cut-like homeobox), Cux-1 (Cut homeobox), Cux-2 and CDP-2. [1] [2] [3] [4] [5] [6] In this text, the terms CDP/Cut and Cut will be used, respectively, to designate mammalian Cut proteins and Cut proteins in general. Cut proteins are unique in that they contain up to four DNA binding domains: the Cut homeodomain and three regions called Cut repeats. [7] [8] [9] [10] How Cut proteins interact with DNA is not well understood, but it is generally supposed that several modes of DNA binding may exist. Interestingly, Cut DNA binding activity was found to be inhibited following phosphorylation of Cut repeats by casein kinase II (CKII) or protein kinase C (PKC), or of the Cut homeodomain by an as yet unknown serine kinase. [11] [12] [13] CDP/Cut proteins were found generally to function as transcriptional repressors. 1, 3, 6, 11, [14] [15] [16] [17] [18] Other results, however, suggested that CDP/Cut may also be able to participate in gene activation. 4, 19 Indeed, CDP/Cut was found to be a component of the promoter complex HiNF-D, which is believed to contribute to the transcriptional induction of several histone genes at the G1/S phase transition of the cell cycle. [19] [20] [21] Mutations in Drosophila cut were shown to cause defects in several tissues including the wings, legs, external sense organs, Malpighian tubules, tracheal system and some structures in the central nervous system. [22] [23] [24] [25] [26] In several tissues, defects caused by cut mutations appeared to result from the fact that some cells had enrolled in the wrong developmental program. [24] [25] [26] [27] From these findings, it was proposed that cut plays an important role in the determination and maintenance of cell-type specificity in several tissues. 28, 29 In mammals, the biological function of CDP/Cut remains to be firmly established, however, it is believed that CDP/Cut plays an equally important role in determining cell-type specificity. In support of this hypothesis, ectopic expression of Cut proteins from Drosophila melanogaster, man or mouse, was shown to have a similar effect on embryonic sensory organ development in Drosophila. 29 Moreover, the 'cut wing' phenotype was rescued by any of these three proteins. 29 The bulk of the results in mammals suggested that CDP/Cut expression or activity may be restricted to proliferating cells. CDP/Cut DNA binding activity, first characterized as the CCAAT displacement activity, was found to disappear upon differentiation of myeloid cells, 14, 15 and expression of the mouse CDP/Cut protein, Cux-1, in the kidney was found to be inversely related to the degree of cellular differentiation. 30 It was thus proposed that mammalian CDP/Cut proteins function as transcriptional repressors that inhibit terminally differentiated gene expression during early stages of differentiation. 14, 15, 30 Moreover, a role for CDP/Cut in cell cycle progression was suggested from the findings that CDP/Cut DNA binding activity oscillates during the cell cycle, reaching a maximum at the end of G1 and during the S phase. 11 Thus, in mammals CDP/Cut clearly plays a role in proliferating cells, but a role for CDP/Cut in determination and maintenance of cell-type specificity has yet to be established.
The coordinated production of hematopoietic cells from a common stem cell is highly regulated by a variety of cytokines (reviewed in Refs 31, 32) . Three experimental approaches have been used to identify transcription factors that play a role in the actualization of the megakaryocytic cell phenotype. The identification within megakaryocytic-specific gene promoters of cis-acting regulatory sequences and their associated DNA binding activities have implicated GATA-1 and 2, [33] [34] [35] [36] [37] [38] [39] 53, 54 (reviewed in Refs [60] [61] [62] [63] . There is at present no single nuclear factor that can distinguish between these two types of cells, although distinct combinations of factors appear to exist in either cell type. 63, 64 In the present study, we have investigated the expression and DNA binding activity of CDP/Cut in cell lines that can be induced to differentiate in vitro. In particular, we have exploited the fact that distinct differentiation pathways can be elicited by the action of different inducers. Our results indicate that while CDP/Cut DNA binding activity is inhibited by phosphorylation in macrophage, granulocyte and erythrocyte-like cells, it remains elevated in megakaryocytes. Sustained CDP/Cut expression and DNA binding activity was confirmed in highly enriched populations of megakaryocytes purified from the bone marrow of mice. Taken together, these results establish that CDP/Cut activity does not uniformly cease as hematopoietic cells differentiate, and suggest that CDP/Cut plays an important role in the megakaryocytic cell lineage. Finally, we discuss the possibility that CDP/Cut activity may be required for endomitosis.
Materials and methods

Cell culture and differentiation
HEL and K562 cells were cultured in suspension in RPMI 1640 medium supplemented with 10% fetal bovine serum (FBS). HL60 cells were grown in the same medium supplemented with 20% FBS. For differentiation, exponentially growing cells were resuspended, at a density about 5 × 10 5 cells/ml for K562 and 2.5 × 10 5 cells/ml for HEL and HL60, in fresh culture medium containing the inducer. Megakaryocytic differentiation of HEL and K562 cells were induced by treatment with 10 nM phorbol 12-myristate 13-acetate (PMA, from Sigma, St Louis, MO, USA), for 4 days. 65, 66 Erythrocytic differentiation of HEL cells was induced by treatment with 60 M hemin chloride bovine (Hemin, from Sigma) for 7 days. 67, 68 Macrophage differentiation of HL60 cells was induced with 10 nM PMA for 3 days. 69, 70 Granulocytic differentiation of HL60 cells was induced either with 1.3% dimethyl sulphoxide (DMSO, from Sigma), or with 2 mM hexamethylene bisacetamide (HMBA, from Sigma) for 7 days. 71 Expanding and purifying murine megakaryocytes BDF-1 mice (Jackson Labs, Bar Harbor, ME, USA) were injected with 0.2 g of pure human TPO per day for 5 days in order to expand the CFU-MK population. After sacrificing the mice, bone marrow was flushed from both femurs and tibias and the cells were cultured for 4 days in serum-free media (Iscove's modified Dulbecco's medium with 1% Nutridoma (Sigma) plus recombinant murine TPO (37.5 ng/ml, conditioned culture supernatant from TPO-secreting Baby Hamster Kidney cells) as previously described. 72, 73 The large, polyploid megakaryocytes were purified using a discontinuous bovine serum albumin density gradient as previously described. 72, 73 All fractions containing a large percentage of megakaryocytes were combined, the cells were recovered by low-speed centrifugation, and the pellet was flash-frozen in dry ice before protein extraction.
Immunofluorescence labeling
Cells were fixed in 3.7% formaldehyde then stained with a murine monoclonal antibody against human CD41 (also called gpllb) (clone SZ22, Immunotech). The primary antibody was revealed using a TRITC-conjugated anti-mouse IgG (Sigma).
FACS analysis
Cells were fixed with 70% ethanol, stained with propidium iodide (Sigma) and submitted to a Facscan flow cytometer (Becton Dickinson, Sparks, MD, USA). 74 Determination of DNA synthesis rate DNA synthesis was investigated by measuring the rate of 3 Hthymidine incorporation as previously described. 75 
Preparation of cell extracts
Cells were incubated for 10 min on ice in 50 mM Hepes pH 7.9, 0.4 M KCl, 4 mM NaF, 4 mM Na 3 VO 4 , 0.2 mM EDTA, 0.2 mM EGTA, 0.1% NP40, 10% glycerol, 1 mM phenylmethylsulfonyl fluoride, proteinase inhibitors cocktail (Roche Diagnostics Indianapolis, IN, USA) and 1 mM dithiothreitol. Total extracts were recovered by centrifugation at 12 000 g for 10 min and retrieval of the supernatant.
Western blot analysis
Protein extracts were recovered as described above and Western blot analysis was performed as previously described 12 with 100 g of proteins.
CDP/Cut antibodies
Polyclonal antibodies against CDP/Cut were generated as previously described using a purified bacterial fusion protein containing amino acids 227 to 1003 of CDP/Cut (GenBank accession number M74099). 13 Monoclonal antibodies against CDP/Cut have been reported. 13 
Electrophoretic mobility shift assays (EMSA)
EMSA were performed with 10 g of protein extracts prepared as described above. A double-stranded oligonucleotide containing a CDP/Cut-consensus binding site (upper strand: 5Ј AAAAGAAGCTTATCGATACCGT 3Ј) was end-labeled using the Klenow polymerase, and 1 ng of the probe was then added to the protein mixture for 15 min. Samples were incubated for 15 min at room temperature in 10 mM Tris pH 7.5, 25 mM NaCl, 1 mM MgCl 2 , 5 mM EDTA pH 8, 5% glycerol, 10 g BSA and 1 mM dithiothreitol. Where indicated, cold competitor DNA (100-fold excess) or 1 l of antibody was added at the same time as the probe. 13 Cold competitor DNA was either the same, unlabeled, DNA as the probe or a mixture of PCR-amplified random oligonucleotides. In some cases (+ phosphatase), extracts were preincubated for 30 min at room 865 temperature with 0.06 U of potato acid phosphatase. After incubation with DNA, samples were then loaded on a 5% polyacrylamide gel (30:1) and separated by electrophoresis at 100 volts for about 1. h in 0.5 × TBE buffer (50 mM Tris, 60 mM boric acid, 1 mM EDTA). Gels were dried and visualized by autoradiography. Although experiments reported throughout this study were performed using total protein extracts, similar results were obtained with nuclear extracts.
Results
CDP/Cut DNA binding activity decreases in HEL cells induced to differentiate into erythrocytes
To investigate CDP/Cut DNA binding during differentiation of erythrocytes, HEL cells were treated with hemin for 7 days. Total protein extracts were prepared at different times and tested for CDP/Cut DNA binding activity in electrophoretic mobility shift assays (EMSA) using radiolabeled oligonucleotides encoding a CDP/Cut consensus binding site ( Figure 1a CDP/Cut DNA binding activity decreases in HEL cells induced to differentiate into erythrocytes. HEL cells were maintained in culture medium supplemented with 60 M hemin. Total protein extracts were prepared at various times and tested for CDP/Cut protein expression (b) and DNA binding activity (a). This experiment was performed at least three times and representative results are shown. (a) Electrophoretic mobility shift assays (EMSA) were done using radiolabeled oligonucleotides encoding a CDP/Cut consensus binding site. Where indicated (+ ␣-Cut Ab, lanes 10 and 11), incubation with DNA was done in the presence of monoclonal anti-CDP/Cut antibodies A and W3. To monitor the effect of phosphorylation (+ phosphatase, lanes 14 and 15), extracts were preincubated for 30 min at room temperature with 0.06 U of potato acid phosphatase. (b) Total protein extracts were subjected to SDS-PAGE, transferred to nitrocellulose and probed with anti-CDP/Cut polyclonal antibodies. 13 Leukemia for CDP/Cut since their formation was inhibited in the presence of monoclonal antibodies directed against CDP/Cut proteins, but not when an unrelated antibody was used ( Figure  1a , lane 10, and data not shown). Accumulating evidence suggests that these two migrating complexes are generated by alternative conformations of the CDP/Cut protein (NS Moon and A Nepveu, manuscript in preparation). After an initial increase in CDP/Cut DNA binding at days 1, 2 and 3 of hemin treatment, we observed a gradual disappearance of the retarded complexes at days 4, 5 and 7 ( Figure 1a, lanes 2-7) .
We have previously shown that phosphorylation of Cut repeats and of the Cut homeodomain can inhibit CDP/Cut DNA binding. [11] [12] [13] To verify whether phosphorylation may regulate CDP/Cut DNA binding in HEL cells, EMSA were repeated this time using extracts that had previously been incubated with a non-specific phosphatase. Treatment of cell extracts with phosphatase increased the intensity of the lower retarded complex from undifferentiated cells (Figure 1a 
Leukemia
CDP/Cut DNA binding activity decreases in HL60 cells induced to differentiate into granulocytes or macrophages
To induce differentiation towards the macrophage lineage, HL60 cells were cultured in the presence of PMA for 3 days and EMSA were performed with total protein extracts. One major retarded complex was observed in untreated HL60 cells (Figure 2a, lane 1) . This retarded complex was specific for CDP/Cut since its formation was inhibited in the presence of monoclonal antibodies directed against CDP/Cut proteins, but not when an unrelated antibody was used (Figure 2a, lane 3 , and data not shown). This complex almost completely disappeared after 3 days of treatment with PMA ( Figure 2a, lane  2) . Thus, in agreement with previous studies, CDP/Cut DNA binding activity disappeared when HL60 cells were induced to differentiate into macrophages. 15, 76, 77 Again, treatment of cell extracts with phosphatase increased the intensity of the retarded complex in undifferentiated cells and also revealed the additional slowly migrating complex (Figure 2a To induce differentiation of HL60 cells into granulocytes, the culture medium was supplemented with either DMSO or HMBA. Protein extracts were prepared on day 7 and tested in EMSA as described above. CDP/Cut DNA binding activity was decreased following treatment with either DMSO or HMBA ( Figure 3a and b, lanes 1 and 2) . These results are also in agreement with those from previous studies. 15, 76, 77 However, CDP/Cut proteins were detected in DMSO or HMBA-treated HL60 cells (Figure 2b, lanes 3 and 4) and treatment of the extracts with a non-specific phosphatase restored CDP/Cut DNA binding, indicating that CDP/Cut proteins are still expressed in these cells but are probably kept inactive as a result of phosphorylation (Figure 3a and b, lanes 5 and 6) .
Altogether, these experiments indicate that CDP/Cut DNA binding activity disappears in differentiating macrophages, granulocytes or erythrocytes but that the protein is still expressed. The possible function and modes of regulation of CDP/Cut in these cells will be addressed in the Discussion.
CDP/Cut DNA binding activity persists in HEL and K562 cells induced to differentiate into megakaryocytes
Two cell lines, HEL and K562, were used to investigate CDP/Cut DNA binding activity during megakaryocytic differentiation. Cells were cultured in the presence of PMA and total protein extracts were prepared at various times and tested in EMSA (Figures 4 and 5) . In contrast to the situation in granulocytes, macrophages and erythrocytes, CDP/Cut DNA binding activity was strong and persisted throughout the entire time course (Figure 4 , lanes 1-5 and Figure 5, lanes 1 and 2) . The specificity of the retarded complexes was confirmed by performing the binding reaction in the presence of either anti-CDP/Cut monoclonal antibodies, or an excess of the same, unlabeled, oligonucleotides (Figure 4 , lanes 6-9, Figure 5 , lanes 3-6). The persistent expression of CDP/Cut during megakaryocytic differentiation was confirmed by Western blot analysis ( Figure 6) .
The above results suggested that within differentiating myeloid cells CDP/Cut activity persists only in megakaryocytes. Because of the novelty of this finding, several parameters were investigated to verify that HEL and K562 cells treated with PMA indeed were induced to differentiate along the megakaryocytic pathway. First, cell counts indicated that CDP/Cut DNA binding activity decreases in HL60 cells induced to differentiate into granulocytes. HL60 cells were maintained for 7 days in culture medium supplemented or not with 1.3% DMSO (a) or 2 mM HMBA (b). This experiment was performed at least three times and representative results are shown. Total protein extracts were prepared and tested for CDP/Cut DNA binding activity as described in Figure 1a .
Figure 4
CDP/Cut DNA binding activity is maintained in HEL cells induced to differentiate into megakaryocytes. HEL cells were maintained in culture medium supplemented with 10 nM PMA. This experiment was performed at least three times and representative results are shown. Total protein extracts were prepared at various times and tested for CDP/Cut DNA binding activity as described in Figure 1a . In the second panel, incubation with DNA was performed in the presence of antibodies or a 100-fold excess cold DNA (unrelated Ab: anti-hematoglutinin; NS cold DNA: a mixture of PCR-amplified random oligonucleotides).
while cells which did not receive PMA continued to multiply, those that were treated with PMA did not increase in number (Figure 7a) . Secondly, HEL cells treated with PMA started to adhere to the bottom of the tissue culture dish and increased in size (Figure 7b) . Moreover, the nuclei of these cells became larger and lobulated (Figure 7b) . Thirdly, immunofluorescence labeling demonstrated that the membrane glycoprotein Ilb (CD41) was expressed at the surface of HEL cells treated with PMA but not of untreated cells (Figure 7b) . Finally, the DNA content of these cells was analyzed by flow cytometry followLeukemia ing cell fixation and labeling with propidium iodide. While in the untreated HEL cell cultures the proportion of cells with 8N content was 2%, this proportion increased to 29% in cultures treated with PMA for 4 days (Figure 7c ). Since endomitosis occurs only in certain specialized cell types, this represents an excellent criterion for megakaryocytic differentiation. We conclude that HEL cultured in the presence of PMA, stopped proliferating and acquired features of differentiated megakaryocytes.
Treatment of K562 cells with PMA did not induce a marked CDP/Cut DNA binding activity is maintained in K562 cells induced to differentiate into megakaryocytes. K562 cells were maintained in culture medium supplemented with 10 nM PMA. This experiment was performed at least three times and representative results are shown. Total protein extracts were prepared at various times and tested for CDP/Cut DNA binding activity as described in Figure 4 .
Figure 6
CDP/Cut protein is expressed in PMA-treated HEL and K562 cells. HEL and K562 cells were cultured for 4 days in the presence (4d PMA) or absence (undifferentiated) of 10 nM PMA. CDP/Cut protein expression was measured by Western blot analysis as described in Figure 1b. differentiation of these cells. Cells stopped dividing ( Figure  7a ), but their size enlargement was minimal and we did not observe an increase in cells having an 8N DNA content (data not shown). However, we noticed an increase in their granulometry index, a quantitative measurement of ␣-granules expression (Figure 7d ). In summary, the degree of megakaryocytic differentiation achieved by K562 cells treated with PMA was weak. Nonetheless, CDP/Cut DNA binding activity remained high in these cells in spite of their growth arrest. This is in contrast with the sharp decrease in CDP/Cut DNA binding activity observed in other cell types upon cessation of cellular proliferation. 11 Thus, results obtained in both K562 and HEL cells revealed that induction of megakaryocytic differentiation, contrary to what is seen in other differentiation pathways, is associated with the maintenance of CDP/Cut expression and DNA binding activity.
CDP/Cut expression and DNA binding activity is detected in purified megakaryocytes isolated from mouse bone marrow
The above results established that CDP/Cut DNA binding activity remained elevated when hematopoietic cell lines were induced to differentiate into megakaryocytes. To verify whether this is also the case in non-transformed cells, murine marrow cells were cultured in thrombopoietin (TPO)-conditioned medium as previously described. 72, 73 A typical ploidy curve of CD41
+ cells in the cell culture after 96 h is presented (Figure 8a) . A large fraction of these cells were polyploid and exhibited DNA contents from 8N to 64N, a feature characteristic of mature megakaryocytes (Figure 8a) . The large, polyploid megakaryocytes were then purified using a discontinuous bovine serum albumin density gradient as previously described, and total protein extracts were used to verify CDP/Cut expression and DNA binding activity. 72, 73 Western blot analysis demonstrated that these cells expressed high level of CDP/Cut protein ( Figure 8b, lanes 2 and 4) . In EMSA, Cut DNA binding activity was detected in two different isolates (Figure 8c, lanes 1 and 3) . The retarded complex disappeared when the reaction was carried in the presence of anti-CDP/Cut antibodies, but was not affected by an unrelated antibody (Figure 8c, lanes 4 and 5) . The retarded complex was also competed with 100-fold molar excess of the same unlabeled oligonucleotides, but not by non-specific DNA ( Figure  8c, lanes 6 and 7) . By these two criteria, the retarded complex involved CDP/Cut. Interestingly, treatment of the total extract with non-specific phosphatase further increased the intensity of this complex, indicating that CDP/Cut DNA binding is still modulated by phosphorylation in fully differentiated megakaryocytes. We conclude that CDP/Cut DNA binding activity is maintained in purified megakaryocytes, albeit to a lower level than seen in HEL or K562 cells treated with PMA.
The persistence of CDP/Cut DNA binding activity in differentiating megakaryocytes may be linked to endomitosis
CDP/Cut DNA binding activity in cycling fibroblastic cells has been found to peak at the G1/S transition and during S phase. 11 This finding raised the possibility that CDP/Cut activity, like E2F, is required to prepare cells for DNA replication. If CDP/Cut was necessary for DNA replication to take place, it would explain why its activity remains elevated in differentiating megakaryocytes but not in other differentiating cells. To begin to test this hypothesis, tritiated-thymidine was used to measure DNA replication in HEL cells treated with hemin (erythroid pathway) or PMA (megakaryocytic pathway). As seen in Figure 9 , in hemin-treated HEL cells tritiated-thymidine incorporation gradually decreased to reach a minimum at days 5, 6 and 7, but in PMA-treated HEL cells it increased at days 2 and 3 and eventually decreased at days 4 and 5. The juxtaposition of these results with EMSA shown in Figures  1 and 4 suggests that there is a good correlation between DNA replication and CDP/Cut DNA binding activity. DNA binding remained elevated in hemin-treated HEL cells at days 1, 2 and 3, but decreased sharply at days 4, 5 and 7 ( Figure 1a, lanes  2-7) . In PMA-treated HEL cells, DNA binding was maximal at day 3 and was slightly reduced at day 4 ( Figure 4 , lanes 4 and 5). Unfortunately, because of the massive cell death that occurred at day 5, we were unable to test DNA binding at this time. In summary, in both the erythroid and megakaryocytic differentiation pathways, our results are consistent with the notion that CDP/Cut DNA binding activity remains elevated for as long as DNA replication takes place.
Discussion
In this study, we have investigated the expression and DNA binding activity of the human CDP/Cut protein in various differentiation pathways of the myeloid cell lineage. Our findings using multipotent myeloid cell lines that can be induced to differentiate in vitro into distinct cell types are summarized in Figure 10 . While CDP/Cut DNA binding activity was found to disappear as cells differentiated into macrophages, granulocytes or erythrocytes, it was sustained in the megakaryocytic pathway. Some of these results are in agreement with previous studies documenting the decline of CDP/Cut DNA binding activity in macrophages and granulocytes. 2, 14, 15, 77 Several novel findings, however, were revealed by the present study. First, the decrease in CDP/Cut DNA binding activity as cells differentiated into erythrocytes was documented for the first Leukemia time. Secondly, in contrast to its DNA binding activity, CDP/Cut expression was maintained in all cell lineages. Thus, the reduction in DNA binding activity, where observed, did not result from a concomitant decrease in protein expression, but instead appeared to result, at least in part, from the phosphorylation of CDP/Cut during differentiation. Indeed, when protein extracts were treated with a non-specific phosphatase, CDP/Cut DNA binding could be restored (see Figures 1-5) . These results indicate that CDP/Cut DNA binding activity, as in other systems, is regulated by phosphorylation. [11] [12] [13] Which DNA binding domain, phosphorylation sites and kinases are involved in each case remain to be investigated. Also, the reason for the persistence of CDP/Cut expression in the absence of activity is not immediately apparent. Perhaps, CDP/Cut plays a role as a scaffolding factor even in the absence of DNA binding, in an analogous manner to the glucocorticoid receptor or the GATA-1 factor. 78, 79 Alternatively, it is possible that protein expression would eventually cease in mature cells, but that cells induced to differentiate in vitro do not reach the same degree of maturity as that achieved in vivo.
In contrast to the situation in macrophages, granulocytes Protein extracts from two different isolates of megakaryocytes were analyzed in lanes 1, 2 and 3, 7. In the second panel, incubation with DNA was performed in the presence of antibodies or a 100-fold excess cold DNA (unrelated Ab: anti-hematoglutinin; NS cold DNA: a mixture of PCR-amplified random oligonucleotides).
Figure 9
Tritiated-thymidine incorporation in HEL cells treated with hemin or PMA. HEL cells were maintained in culture medium supplemented with either 60 M hemin or 10 nM PMA. At the indicated times, 3 H-thymidine was added to the medium, cells were harvested 2 h later and 3 H-thymidine incorporation in genomic DNA was measured. Each point represents the mean of three experiments. and erythrocytes, both CDP/Cut protein expression and DNA binding activity were sustained when cells were induced to differentiate into megakaryocytes. This result is important as it demonstrates that CDP/Cut activity in mammals can be observed in certain differentiated cells. Moreover, this is compatible with the notion that CDP/Cut may be involved in the determination of cell type identity in mammals. According to this hypothesis, the persistence of CDP/Cut activity during final maturation would contribute to direct myelo-erythroid precursor cells towards the megakaryocytic pathway. An alternative hypothesis may be suggested from the regulation of CDP/Cut activity in proliferating fibroblastic cells. It was found that CDP/Cut is expressed in all phases of the cell cycle but is active in DNA binding only at the end of G1 and during S phase. 11 This finding implies that CDP/Cut plays a role in cell cycle progression and raises the possibility that CDP/Cut function is required, directly or indirectly, for DNA replication. Interestingly, megakaryocytes are unique among terminally differentiated cells in that they continue to replicate their DNA in the absence of cellular division, a process that has been referred to as endomitosis. Thus, it is possible that the maintenance of CDP/Cut activity in these cells is related to its putative role in DNA replication. Two sets of results are in agreement with this hypothesis. First, CDP/Cut DNA binding activity was found to follow closely the rate of DNA synthesis in HEL cells induced to differentiate into either erythrocytes or megakaryocytes (compare EMSA in Figures 1 and 4 with 3 H-thymidine incorporation in Figure 9 ). Secondly, higher CDP/Cut DNA binding activity was observed in HEL and K562 cell lines following induction of megakaryocytic differentiation in vitro than in mature, primary, murine megakaryocytes. It is striking that the DNA content of the cell lines was 8N at the highest, while it was as high as 64N in the case of primary megakaryocytes. It could be assumed that DNA replication was about to stop in primary megakaryocytes while it was still underway in the in vitro differentiation system.
In summary, our results revealed that the activity of the CDP/Cut transcription factor is not uniformly downmodulated as myeloid cells differentiate but remains elevated in megakaryocytes. Since cut has been shown in Drosophila to be involved in cell-type specification, it is tempting to speculate that it fulfills a similar function in mammals, in particular within the myelo-erythroid lineage. Alternatively, the maintenance of CDP/Cut activity in megakaryocytes may be linked to its putative role in DNA replication. Future studies involving forced expression of CDP/Cut within multipotential progenitors as well as gene targeting experiments should help resolve this question.
